

HY-P1698 · 5 mg
MedChemExpress · Cat: HY-P1698
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/reltecimod.html
Description
Reltecimod AB-103 is a T-cell-specific surface glycoprotein CD28 TP44 antagonist. Reltecimod has beneficial effects against different bacterial infections, their exotoxins and endotoxins, and ionizing radiation. Reltecimod modulates the inflammatory response by targeting and attenuating the critical CD28/B7-2 co-stimulatory pathway, without inhibiting it. Reltecimod can be used to research necrotizing soft-tissue infections NSTIs .







